Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20039429rdf:typepubmed:Citationlld:pubmed
pubmed-article:20039429lifeskim:mentionsumls-concept:C2926606lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0024143lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0010583lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C2607943lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0209368lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:20039429lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:20039429pubmed:issue1lld:pubmed
pubmed-article:20039429pubmed:dateCreated2010-1-13lld:pubmed
pubmed-article:20039429pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:abstractTextTo assess the effect of mycophenolate mofetil compared with intravenous pulses of cyclophosphamide on the nonrenal manifestations of lupus nephritis.lld:pubmed
pubmed-article:20039429pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:languageenglld:pubmed
pubmed-article:20039429pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:citationSubsetAIMlld:pubmed
pubmed-article:20039429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20039429pubmed:statusMEDLINElld:pubmed
pubmed-article:20039429pubmed:monthJanlld:pubmed
pubmed-article:20039429pubmed:issn0004-3591lld:pubmed
pubmed-article:20039429pubmed:authorpubmed-author:GordonCarolin...lld:pubmed
pubmed-article:20039429pubmed:authorpubmed-author:IsenbergDavid...lld:pubmed
pubmed-article:20039429pubmed:authorpubmed-author:GinzlerEllen...lld:pubmed
pubmed-article:20039429pubmed:authorpubmed-author:WofsyDavidDlld:pubmed
pubmed-article:20039429pubmed:authorpubmed-author:LiskLauraLlld:pubmed
pubmed-article:20039429pubmed:authorpubmed-author:DooleyMary-An...lld:pubmed
pubmed-article:20039429pubmed:authorpubmed-author:ALMS Grouplld:pubmed
pubmed-article:20039429pubmed:issnTypePrintlld:pubmed
pubmed-article:20039429pubmed:volume62lld:pubmed
pubmed-article:20039429pubmed:ownerNLMlld:pubmed
pubmed-article:20039429pubmed:authorsCompleteYlld:pubmed
pubmed-article:20039429pubmed:pagination211-21lld:pubmed
pubmed-article:20039429pubmed:dateRevised2010-10-13lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:meshHeadingpubmed-meshheading:20039429...lld:pubmed
pubmed-article:20039429pubmed:year2010lld:pubmed
pubmed-article:20039429pubmed:articleTitleNonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.lld:pubmed
pubmed-article:20039429pubmed:affiliationState University of New York Downstate Medical Center, Brooklyn, NY, USA.lld:pubmed
pubmed-article:20039429pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20039429pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:20039429pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20039429pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20039429pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20039429lld:pubmed